KWSE:NIH Statistics

Total Valuation

KWSE:NIH has a market cap or net worth of KWD 48.43 million. The enterprise value is 54.18 million.

Market Cap	48.43M
Enterprise Value	54.18M

Important Dates

The last earnings date was Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	Jul 9, 2024

Share Statistics

KWSE:NIH has 231.73 million shares outstanding. The number of shares has increased by 0.24% in one year.

Current Share Class	n/a
Shares Outstanding	231.73M
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	+1.59%
Owned by Insiders (%)	6.55%
Owned by Institutions (%)	n/a
Float	145.51M

Valuation Ratios

The trailing PE ratio is 29.22.

PE Ratio	29.22
Forward PE	n/a
PS Ratio	5.86
PB Ratio	1.25
P/TBV Ratio	1.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.32, with an EV/FCF ratio of -45.71.

EV / Earnings	33.04
EV / Sales	6.63
EV / EBITDA	14.32
EV / EBIT	15.03
EV / FCF	-45.71

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.05.

Current Ratio	2.87
Quick Ratio	2.67
Debt / Equity	0.05
Debt / EBITDA	0.66
Debt / FCF	-2.09
Interest Coverage	16.42

Financial Efficiency

Return on equity (ROE) is 3.92% and return on invested capital (ROIC) is 4.51%.

Return on Equity (ROE)	3.92%
Return on Assets (ROA)	4.03%
Return on Invested Capital (ROIC)	4.51%
Return on Capital Employed (ROCE)	6.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.15
Inventory Turnover	3.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.29% in the last 52 weeks. The beta is 0.02, so KWSE:NIH's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	+52.29%
50-Day Moving Average	0.20
200-Day Moving Average	0.20
Relative Strength Index (RSI)	63.71
Average Volume (20 Days)	4,714,409

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KWSE:NIH had revenue of KWD 8.18 million and earned 1.64 million in profits. Earnings per share was 0.01.

Revenue	8.18M
Gross Profit	5.23M
Operating Income	3.61M
Pretax Income	1.87M
Net Income	1.64M
EBITDA	3.78M
EBIT	3.61M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 5.45 million in cash and 2.48 million in debt, giving a net cash position of 2.97 million or 0.01 per share.

Cash & Cash Equivalents	5.45M
Total Debt	2.48M
Net Cash	2.97M
Net Cash Per Share	0.01
Equity (Book Value)	47.36M
Book Value Per Share	0.17
Working Capital	7.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.10 million and capital expenditures -80,357, giving a free cash flow of -1.19 million.

Operating Cash Flow	-1.10M
Capital Expenditures	-80,357
Free Cash Flow	-1.19M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 64.01%, with operating and profit margins of 44.10% and 20.06%.

Gross Margin	64.01%
Operating Margin	44.10%
Pretax Margin	22.82%
Profit Margin	20.06%
EBITDA Margin	46.29%
EBIT Margin	44.10%
FCF Margin	n/a

Dividends & Yields

KWSE:NIH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	1
Payout Ratio	80.45%
Buyback Yield	-0.24%
Shareholder Yield	-0.24%
Earnings Yield	3.39%
FCF Yield	-2.45%

Dividend Details

Stock Splits

The last stock split was on July 18, 2022. It was a forward split with a ratio of 1.03.

Last Split Date	Jul 18, 2022
Split Type	Forward
Split Ratio	1.03

Scores

KWSE:NIH has an Altman Z-Score of 2.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.99
Piotroski F-Score	n/a